Does the choice of drug in pharmacologic cardioversion correlate with the guidelines? Systematic review.

  title={Does the choice of drug in pharmacologic cardioversion correlate with the guidelines? Systematic review.},
  author={Janusz Springer and Tomasz Szmuda and Dariusz Kozłowski},
  journal={Advances in clinical and experimental medicine : official organ Wroclaw Medical University},
BACKGROUND Atrial fibrillation (AF) is the most common sustained arrhythmia, the most common cause of supraventricular tachycardia in the global population and the most common arrhythmia requiring treatment in an emergency department. OBJECTIVES To systematically review recent literature and quantify the correlation between the choice of pharmacological cardioversion (PCV) drug and the national or international guidelines. MATERIAL AND METHODS A systematic review was performed in accordance… 

Tables from this paper


Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
Antazoline represents an efficacious and safe method of pharmacological cardioversion in a real‐life setting of atrial fibrillation with intravenous antazoline in the setting of the emergency department.
The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department
The epidemiology and management of recent-onset AF presenting to one large tertiary ED is comparable with previous publications, and variations in management and the lack of robust evidence guiding the management are mirror the literature.
Comparative effectiveness and safety of antazoline‑based and propafenone‑based strategies for pharmacological cardioversion of short‑duration atrial fibrillation in the emergency department.
The antazoline‑based strategy was more effective and safer in comparison with propafenone‑based strategy in the pharmacological cardioversion of short‑duration AF in the emergency department.
[Vernakalant in hospital emergency practice: safety and effectiveness].
Vernakalant is effective and safe for restoring sinus rhythm in the hospital emergency department and factors associated with a more effective response are evaluated.
Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study)
  • A. Maciąg, M. Farkowski, H. Szwed
  • Medicine
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2017
Intravenous antazoline was effective and safe in the rapid conversion of non-valvular paroxysmal atrial fibrillation to sinus rhythm in patients without heart failure.